Mukka Proteins growth over the years

·FMCG & RetailChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr2 yr
Revenue+44.1%+2.5%
EBITDA+20.8%+4.2%
Net Income+18.7%−12.4%
EPS (adj.)+12.1%−13.8%
Total Assets+50.7%+31.3%
Total Equity+15.8%+13.8%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MUKKA₹24.68

Mukka Proteins Limited

· FMCG & Retail
₹ CrorePeersNARMADAKSEMcap ₹740 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
2Y
CAGR
Revenue+44.1+2.5
EBITDA+20.8+4.2
Net Income+18.7-12.4
EPS (adj.)+12.1-13.8
Total Assets+50.7+31.3
Total Equity+15.8+13.8
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.